Stay updated with breaking news from Bowel Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 3b results show risankizumab is superior for endoscopic remission and clinical remission at week 48 compared with ustekinumab, a "once in a career" result, study authors say.
The most comprehensive study to date suggests an estimated 2.4 million Americans have clinically diagnosed inflammatory bowel disease, and up to 56,000 new cases are diagnosed each year.
/PRNewswire/ -- Faecal incontinence is one of the most prevalent path-physiological medical problems that affects the elderly and women across the world....
- Companies are creating bowel management systems with characteristics such as extra active carbon filter and unique odor-proof coating in the collecting bag. - Bowel management systems